Sysmex Astrego is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. The company was founded as Astrego Diagnostics AB in March 2017 with the mission to help in the global fight against antimicrobial resistance (AMR). Astrego Diagnostics was acquired by Sysmex Corporation, Japan in May 2022.
The company name comes from Antibiotic Susceptibility Testing – AST, and rego – being latin for guide, steer or manage. Our products are designed to guide physicians in the selection of effective antibiotic treatments to improve patient outcomes and make antibiotic stewardship easy.
Our team combines multidisciplinary scientific excellence with seasoned entrepreneurs and diagnostic industry management.
The company quality management system is certified according to ISO 13485:2016.